Author Affiliations: David G. Cogan Laboratory of Ophthalmic Pathology and Division of Oculoplastic Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston.
Systemic T-cell lymphomas metastatic to the orbit are much rarer than non-Hodgkin B-cell neoplasms (predominantly marginal zone and follicular).1 We describe an adult with an Epstein-Barr virus (EBV)–positive T-cell lymphoma of the lacrimal gland associated with multiorgan disease that was not of the expected natural killer/T-cell subtype.2 Because of the unusual clinical findings and imaging study results, the diagnosis was elusive. A lacrimal biopsy evaluated with an EBV probe established the correct diagnosis; this technique should probably be used for all unusual or atypical orbital lymphomas.
A 57-year-old man developed abrupt right eye swelling and erythema with chemosis that worsened over 6 days and was nonresponsive to intravenous antibiotics (Figure 1A). He had had a febrile illness with fatigue for 4 years. Earlier lung, liver, and bone marrow biopsies revealed an EBV-positive T-cell lymphoma with a clonal rearrangement of the T-cell receptor gene. Visual acuity was 20/20 OU. The motility was moderately decreased and there was no proptosis. Magnetic resonance imaging showed enlargement of the lacrimal gland on the right side with a nonenhancing center (Figure 1A) and bilateral involvement of the extraocular muscles (Figure 1B). Biopsy of the periorbita (Figure 1C) and lacrimal gland (Figure 1D) showed chronic inflammation with necrosis (Figure 1C and D) and scattered larger cells with ground-glass nuclei (Figure 1C). The lymphocytes were positive for CD3 and CD5 (Figure 2A) and negative for CD56; there were rare CD20-positive cells. Brown-Hopps, Steiner, and Gomori methenamine silver stains disclosed no organisms. In situ hybridization with an EBV probe demonstrated marked positivity in the lymphocytes in both the periorbita and lacrimal gland (Figure 2B). The lung biopsy showed a striking perivascular lymphocytic distribution (Figure 2C) with identical immunohistochemical and EBV-positive (Figure 2D) findings. Radiotherapy delivered to both orbits caused complete resolution of the patient's symptoms, and he has recently received an allogenic bone marrow transplant.
Figure 1. Magnetic resonance imaging, clinical, and biopsy findings. A, Coronal projection of a magnetic resonance imaging scan reveals a large area of central lucency (arrow) in an enlarged lacrimal gland, consistent with extensive necrosis or a sterile abscess. Inset, Swollen, erythematous right upper eyelid with prolapse of the chemotic conjunctiva. B, Swelling is present bilaterally and more posteriorly in the orbit's lateral rectus muscle (arrows) and inferior rectus muscle (arrowheads). The optic nerves (ON) are not compressed. C, Focal hemorrhagic necrosis in the periorbita (hematoxylin-eosin, original magnification ×100). Inset, Large nuclei with a ground-glass characteristic (arrows) suggestive of viral infection (hematoxylin-eosin, original magnification ×400). D, Abundant inflammatory cells are present between the acini (AC) of the lacrimal gland (hematoxylin-eosin, original magnification ×100). Inset, Focus of granular necrosis of the lacrimal parenchyma (hematoxylin-eosin, original magnification ×100).
Figure 2. Histopathologic findings. A, In the lacrimal gland, the CD3-positive T-lymphocytic population is intense (immunoperoxidase reaction, toluidine blue with diaminobenzidine chromogen, original magnification ×200). B, Plentiful Epstein-Barr virus–positive T lymphocytes are located between the acini (AC) of the lacrimal gland parenchyma (in situ hybridization with Epstein-Barr virus probe, original magnification ×100). ID indicates intralobular duct. C, The lung biopsy manifests a lymphocytic infiltrate with striking perivascular cuffing toward the bottom right (hematoxylin-eosin, original magnification ×25). Inset, The cells are shown to be CD3-positive T lymphocytes (immunoperoxidase reaction, toluidine blue with diaminobenzidine chromogen, original magnification ×100). D, Epstein-Barr virus–positive lymphocytes are responsible for the perivascular lung infiltrate (in situ hybridization with Epstein-Barr virus probe, original magnification ×100).
Ascending ductular and hematogenous infections of the lacrimal gland are vanishingly rare. Our patient's orbital “cellulitis” with lacrimal gland cavitation and no response to antibiotic therapy was confusing. The biopsy revealed necrosis of the lacrimal gland (probably at the margins of a sterile abscess) and the profuse presence of CD3- and CD5-positive T lymphocytes that were CD56 negative, thereby ruling out a natural killer/T-cell lymphoma. The number of T cells was much greater than that normally expected in the gland,3 and in situ hybridization established T-cell EBV positivity.
The liver biopsy had disclosed that the lymphocytic infiltrate showed a monoclonal T-cell receptor gene rearrangement, rendering the condition a true lymphoma rather than a lymphoproliferative disorder. Angiodestruction and necrosis frequently accompany EBV-induced lymphoproliferations by means of locally released chemokines4; an open lung biopsy displayed a prominent tendency for vascular cuffing by EBV-positive T cells. The multisystem involvement of lung, liver, and bone marrow and the favorable response to bilateral orbital radiotherapy support the neoplastic character of the condition.
The closest analog to the current lesion is the T-cell lymphoproliferative disorder of childhood without a known clonal rearrangement.5,6 To our knowledge, our case is the first orbital example of an EBV-positive monoclonal T-cell lymphoma not of the natural killer/T-cell subtype in an adult.7 The EBV-positive lymphomas of the orbit have mostly, but not exclusively, been B-cell neoplasms such as Burkitt lymphoma, lymphomatoid granulomatosis, and AIDS-associated and posttransplantation lymphomas.4,8,9 Orbital natural killer/T-cell lymphoma (CD3, CD5, and CD56 positive) with EBV infection can also cause a clinical inflammatory picture.10
Correspondence: Dr Jakobiec, David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear Infirmary, 243 Charles St, Room 321, Boston, MA 02114 (firstname.lastname@example.org).
Financial Disclosure: None reported.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Ophthalmology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.